SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 42.73 |
| Enterprise Value ($M) | 27.73 |
| Book Value ($M) | 14.96 |
| Book Value / Share | 0.36 |
| Price / Book | 2.86 |
| NCAV ($M) | 14.52 |
| NCAV / Share | 0.35 |
| Price / NCAV | 2.94 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.51 |
| Return on Assets (ROA) | -1.28 |
| Return on Equity (ROE) | -1.54 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 17.52 |
| Current Ratio | 17.52 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 15.40 |
| Assets | 15.84 |
| Liabilities | 0.88 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Mangrove Partners | 6.15 | ||
| 13D/A | English Aron R. | 51.10 | 0.00 | |
| 13G | Nantahala Capital Management, LLC | 8.63 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 202 | 3,906 | 5.17 | |
| 808 | 1,534 | 52.67 | |
| 14,867 | 37,736 | 39.40 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ALGS – Aligos Therapeutics, Inc. | ALTS – JanOne Inc. |
| ALZN – Alzamend Neuro, Inc. | ANIX – Anixa Biosciences, Inc. |
| APM – Aptorum Group Limited |
Financial data and stock pages provided by
Fintel.io